| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 48.87B | 50.98B | 50.09B | 58.27B | 40.01B | 38.41B |
| Gross Profit | 48.87B | 47.08B | 48.80B | 56.48B | 38.92B | 36.99B |
| EBITDA | 9.86B | 12.33B | 11.20B | 10.02B | 12.74B | 11.60B |
| Net Income | 7.12B | 6.81B | 7.29B | 5.55B | 7.95B | 6.64B |
Balance Sheet | ||||||
| Total Assets | 3.46T | 3.38T | 3.31T | 3.32T | 3.63T | 3.33T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 178.83B | 217.36B | 411.09B | 643.72B | 335.62B |
| Total Debt | 188.11B | 182.87B | 66.57B | 8.36B | 294.66B | 152.52B |
| Total Liabilities | 3.30T | 3.21T | 3.14T | 3.17T | 3.48T | 3.17T |
| Stockholders Equity | 165.62B | 160.07B | 168.09B | 149.82B | 154.48B | 158.40B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 41.29B | 25.64B | -364.04B | 0.00 | 223.08B |
| Operating Cash Flow | 0.00 | 42.36B | 26.64B | -362.23B | 0.00 | 224.25B |
| Investing Cash Flow | 0.00 | -132.58B | -95.86B | 131.79B | 9.90B | -128.31B |
| Financing Cash Flow | 0.00 | 52.88B | -54.44B | -1.86B | 165.98B | -2.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥101.82B | 1.54 | ― | 3.05% | 8.75% | -12.68% | |
69 Neutral | ¥102.19B | 6.66 | ― | 2.46% | 9.12% | 43.43% | |
69 Neutral | ¥67.24B | 6.31 | ― | 2.34% | -0.97% | 27.62% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | ¥963.61B | 8.76 | ― | 2.10% | 1.39% | 52.58% | |
65 Neutral | ¥252.44B | 10.90 | ― | 2.53% | 7.67% | 11.03% | |
65 Neutral | ¥11.00B | 8.64 | ― | 2.74% | 7.74% | -92.49% |